FindTrial
Sign In

A multicenter study on the use of methoxamine in septic shock patients with tachycardia

A multicenter study on the use of methoxamine in septic shock patients with tachycardia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073836
Enrollment
Unknown
Registered
2023-07-24
Start date
2023-07-24
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic shock with tahcycardia

Interventions

Study group:methoxamine
Control group:esmolol

Sponsors

Cancer Hospital of Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Septic shock patients with tachycardia (heart rate larger than 95 bpm)

Exclusion criteria

Exclusion criteria: ?patients estimated to be live less than 24 hours ?patients are reluctant to participate in research

Design outcomes

Primary

MeasureTime frame
Heart rate;—

Secondary

MeasureTime frame
TnT;Blood lactic acid level;Day 28 mortality rate;—

Countries

China

Contacts

Public ContactXuezhong Xing

Cancer Hospital of Chinese Academy of Medical Sciences

xingxuezhong@cicams.ac.cn+86 10 8778 8257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026